Bioxyne Balance Sheet Health
Financial Health criteria checks 6/6
Bioxyne has a total shareholder equity of A$2.7M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$4.7M and A$2.1M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
Interest coverage ratio | n/a |
Cash | AU$1.53m |
Equity | AU$2.67m |
Total liabilities | AU$2.06m |
Total assets | AU$4.74m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BXN's short term assets (A$4.7M) exceed its short term liabilities (A$2.1M).
Long Term Liabilities: BXN has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BXN is debt free.
Reducing Debt: BXN had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BXN has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: BXN is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.